1. Inicio
  2. Proyectos y Estudios
  3. AN OPEN-LABEL, ACTIVE-CONTROLLED, SAFETY AND EFFICACY STUDY OF ORAL BARICITINIB IN PATIENTS FROM 2 YEARS TO LESS THAN 18 YEARS OLD WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED UVEITIS OR CHRONIC ANTERIOR ANTINUCLEAR ANTIBODY POSITIVE UVEITIS.

AN OPEN-LABEL, ACTIVE-CONTROLLED, SAFETY AND EFFICACY STUDY OF ORAL BARICITINIB IN PATIENTS FROM 2 YEARS TO LESS THAN 18 YEARS OLD WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED UVEITIS OR CHRONIC ANTERIOR ANTINUCLEAR ANTIBODY POSITIVE UVEITIS.

Datos básicos

ENSAYO CLÍNICO EUROPEA I4V-MC-JAHW 2019-000119-10 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2020

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

LILLY, S.A.

Cita

Compartir